FindTrial
Sign In

Retrospective analysis of insulinoma cases

Retrospective analysis of insulinoma cases evaluated at a tertiary care referral centre in western India

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025463
Enrollment
100
Registered
2020-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E168- Other specified disorders of pancreatic internal secretion

Interventions

None listed

Sponsors

Department of Endocrinology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of clinically ,biochemically, imaging based and/or histopathologically confirmed cases of insulinoma evaluated at KEM Hospital, Parel from 1998 till date.

Exclusion criteria

Exclusion criteria: 1)Incompletely archived data. 2)Unestablished diagnosis and incomplete evaluation. 3)Autoimmune hypoglycaemia syndrome 4)Drug induced hypoglycaemia

Design outcomes

Primary

MeasureTime frame
Clinical spectrum of insulinoma casesTimepoint: 3 months—

Secondary

MeasureTime frame
Sensitivity and specificity of functional imaging in insulinoma localizationTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Tushar Bandgar

Department of Endocrinology, Seth G.S.Medical college and KEM hospital

anuraglila@gmail.com9820025037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026